HUABO JITUAN

huabo-jituan-logo

Huabo Jituan provides software, hardware development, system integration, website construction, and technical services.

#SimilarOrganizations #Financial #More

HUABO JITUAN

Industry:
Financial Services Hardware Information Services Information Technology Software

Founded:
1999-01-01

Status:
Active

Contact:
021-31198999

Email Addresses:
[email protected]

Technology used in webpage:
China Ministry Of Public Security


Similar Organizations

advanced-integration-technology-logo

Advanced Integration Technology

Advanced Integration Technology offers hardware and software product sales, IT infrastructure construction, and system development services.

cxr-engineering-logo

CXR Engineering

CXR Engineering focuses on Planning, design, development, operation and sales of crypto asset exchange system, FX exchange system, and more.

not_available_image

Micro Design

Micro Design designs and develops various measuring instruments, inspection instruments, control instruments, medical devices, etc.

quix-logo

Quix

Quix provides software solutions for measurement, engineering works, and construction areas.

swiftness-logo

Swiftness

Swiftness offers a digital platform that creates a significant upgrade in the pension savings market.

Investments List

Date Company Article Money raised
2017-11-28 A-Life Huabo Jituan investment in Series A - A-Life 10 M CNY
2017-03-29 Nibiru Technology Huabo Jituan investment in Series B - Nibiru Technology 20 M CNY

More informations about "Huabo Jituan"

Huabo Jituan - Investments, Portfolio & Company Exits - Crunchbase

Huabo Jituan has made 2 investments. Their most recent investment was on Nov 28, 2017, when A-Life raised. obfuscated. obfuscated. How many investments has this organization made โ€ฆSee details»

A-Life - Funding, Financials, Valuation & Investors - Crunchbase

Huabo Jituan and Xiaomi are the most recent investors. Unlock for free . Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 3. Total Funding Amount . ... How much โ€ฆSee details»

Huabo Jituan โ€” 2 Portfolio companies, 2 Investments, Team

Huabo Jituan. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom list of funds. โ€ฆSee details»

A-Life - Web3 Crypto Company Profile, Funding, Valuation, โ€ฆ

A-Life is engaged in cotton towel business.See details»

TTFB Company Limited - Wikipedia

TTFB Company Limited (TTFB; Chinese: ็“ฆๅŸŽๆณฐ็ตฑ้›†ๅœ˜; pinyin: WวŽchéngtàitว’ng Jítuán) is a multi-brand restaurant operator headquartered in New Taipei, Taiwan.The company owns and โ€ฆSee details»

China International Communications Group - Wikipedia

China International Communications Group (CICG) is a foreign-language publishing and communications organization headquartered in Beijing, China, and owned and operated by โ€ฆSee details»

Shanghai United Media Group - Wikipedia

Shanghai United Media Group (Chinese: ไธŠๆตทๆŠฅไธš้›†ๅ›ข) is a state media company of the People's Republic of China, established on October 28, 2013, through the merger of the city's two โ€ฆSee details»

RX China | RX - RX: Global

Boasting more than 40 years of rapid growth, RX has made its name as a well-respected and professional event organizer in China. It employs about 500 people and owns a fleet of wholly-owned companies and joint ventures that host a โ€ฆSee details»

PSLab - Crunchbase

PSLab, DMM.make AKIBA, Huabo Jituan, and IEG are involved in the hardware and technology sector. PSLab focuses on open source hardware for educational and experimental purposes. โ€ฆSee details»

Huabo Biopharm (Shanghai) Co., Ltd.

Huaota entered into an agreement with Shanghai Junshi Biosciences Co., Ltd and Junshi acquired the Avastin monoclonal antibody biosimilar (project code "HOT-1010") from Huaota โ€ฆSee details»

Huabo Biopharm (Shanghai) Co., Ltd.-The First Subject Has Been ...

Today, a patient of Shanghai Chest Hospital, as the first subject, was administrated with HOT-1030, a recombinant humanized IgG1 type anti-CD137 (also known as 4-1BB) monoclonal โ€ฆSee details»

HB-0052 - Drug Targets, Indications, Patents - Synapse - Patsnap

Dec 7, 2024 HB-0052: a CD73 inhibitors Drug, Initially developed by Huabo Biopharm Co Ltd., Now, its global highest R&D status is Phase 1, Mechanism: CD73 inhibitors(5'-nucleotidase โ€ฆSee details»

CXR Engineering - Crunchbase

CXR Engineering focuses on planning, design, development, operation, and sales of crypto asset exchange systems and FX exchange systems.See details»

Huabo Biopharm (Shanghai) Co., Ltd.-ๆ–ฐ้—ป่ต„่ฎฏ

The much-anticipated 32nd EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) will be held in Berlin, Germany, from October 11 to 14, 2023.See details»

Myanmar: Workers at Huabo Time garment factory reportedly โ€ฆ

In July 2023, it was reported that workers at Huabo Time were facing rights violations, including physical and verbal abuse inflicted by one of the supervisors, and an employer-run union that โ€ฆSee details»

Chinese accused embezzler in Canada: report | CBC News

Feb 22, 2011 A low-ranking official accused of embezzling nearly $14 million has fled to Canada, Chinese media report. Li Huabo, director of the economy and construction unit of Poyang โ€ฆSee details»

ausLink Group - Crunchbase Company Profile & Funding

Organization. ausLink Group . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Alternatives and possible competitors to ausLink Group may โ€ฆSee details»

Recibokibart - Drug Targets, Indications, Patents - Synapse - Patsnap

Nov 29, 2024 The decision to pursue a monoclonal antibody (mAb) as a therapeutic for disease intervention requires the assessment of many factors, such as target-biology, including the โ€ฆSee details»

Swiftness - Crunchbase Company Profile & Funding

Alternatives and possible competitors to Swiftness may include MUSLIMPOCKET, Financial Information System, and Huabo Jituan. Unlock even more features with Crunchbase Pro Start โ€ฆSee details»

linkstock.net © 2022. All rights reserved